Literature DB >> 16765661

PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts.

Jeanne M Nervina1, Clara E Magyar2, Flavia Q Pirih2, Sotirios Tetradis3.   

Abstract

Parathyroid hormone (PTH) potently activates cAMP-protein kinase A (PKA)-driven molecular cascades in osteoblasts. The NR4A/NGFI-B orphan nuclear receptor (NR) Nurr1 is a PTH-induced, cAMP-responsive primary response gene (PRG) that transactivates osteocalcin (Ocn) expression through a putative NGFI-B response element (NBRE) in the proximal promoter. As a true orphan NR, Nurr1's expression level and coactivator recruitment regulate its transactivation capacity. We postulated that Nurr1's induction through cAMP-PKA signaling might favor a coactivator that is likewise cAMP-dependent. A possible candidate is the cAMP-inducible coactivator PPARgamma coactivator-1alpha (PGC-1alpha). We hypothesize that PGC-1alpha is a PTH-induced PRG that synergizes with Nurr1 to induce target gene transcription in osteoblasts. We show that 10 nM PTH for 2 h maximally induced PGC-1alpha mRNA in primary mouse osteoblasts (MOBs) and calvariae. Selective signaling agonists and antagonists demonstrated that PTH induced PGC-1alpha mRNA primarily through the cAMP-PKA pathway. Protein synthesis inhibition sustained PTH-induced PGC-1alpha expression. PGC-1alpha enhanced Nurr1-induced transactivation of a consensus 3xNBRE-luciferase construct and the rat (-1050)Ocn promoter-luciferase construct from 3.7- to 9.6- and 10.1-fold, respectively. This synergy required Nurr1-DNA binding, since a mutation of the Ocn promoter NBRE abolished both Nurr1- and Nurr1-PGC-1alpha-induced transactivation. Using GST pull-down assays, PGC-1alpha directly interacted with in vitro-generated and nuclear Nurr1. We conclude that PGC-1alpha is a PTH-induced, cAMP-dependent PRG that directly synergizes with Nurr1 to transactivate target genes in osteoblasts. Taken together with published data, our findings suggest that Nurr1 and PGC-1alpha may be pivotal mediators of cAMP-induced osteoblast gene expression and osteoblast function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765661     DOI: 10.1016/j.bone.2006.04.023

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  14 in total

1.  Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.

Authors:  Jillian N Collins; Beth J Kirby; Janine P Woodrow; Robert F Gagel; Clifford J Rosen; Natalie A Sims; Christopher S Kovacs
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

2.  Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.

Authors:  Paul Childress; Binu K Philip; Alexander G Robling; Angela Bruzzaniti; Melissa A Kacena; Nicoletta Bivi; Lilian I Plotkin; Aaron Heller; Joseph P Bidwell
Journal:  Calcif Tissue Int       Date:  2011-05-24       Impact factor: 4.333

3.  Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1.

Authors:  Jennifer A Ralph; Afsar U Ahmed; Leilani L Santos; Andrew R Clark; Jason McMorrow; Evelyn P Murphy; Eric F Morand
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

Review 4.  Mitochondrial biogenesis and healthy aging.

Authors:  Guillermo López-Lluch; Pablo M Irusta; Placido Navas; Rafael de Cabo
Journal:  Exp Gerontol       Date:  2008-07-09       Impact factor: 4.032

5.  Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation.

Authors:  Joseph J Belanto; Silvia V Diaz-Perez; Clara E Magyar; Michele M Maxwell; Yasemin Yilmaz; Kasey Topp; Guney Boso; Catriona H Jamieson; Nicholas A Cacalano; Christina A M Jamieson
Journal:  Neuromuscul Disord       Date:  2010-01-18       Impact factor: 4.296

Review 6.  Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia.

Authors:  Anuradha Kalani; Pradip K Kamat; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.396

7.  Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids.

Authors:  Wendy Tseng; Jinxiu Lu; Gail A Bishop; Andrew D Watson; Andrew P Sage; Linda Demer; Yin Tintut
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

Review 8.  The Novel Role of PGC1α in Bone Metabolism.

Authors:  Cinzia Buccoliero; Manuela Dicarlo; Patrizia Pignataro; Francesco Gaccione; Silvia Colucci; Graziana Colaianni; Maria Grano
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 9.  PGC-1: a key regulator in bone homeostasis.

Authors:  Haoling Chen; Wenguo Fan; Hongwen He; Fang Huang
Journal:  J Bone Miner Metab       Date:  2021-08-23       Impact factor: 2.626

10.  A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.

Authors:  Omer Raheem; Anna A Kulidjian; Christina Wu; Young B Jeong; Tomonori Yamaguchi; Kristen M Smith; Daniel Goff; Heather Leu; Sheldon R Morris; Nicholas A Cacalano; Koichi Masuda; Catriona H M Jamieson; Christopher J Kane; Christina A M Jamieson
Journal:  J Transl Med       Date:  2011-10-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.